GLB1 and GM1 gangliosidosis: Differences in clinical score between Glb1-/- and Glb1+/+ mice towards the end of the experiment are likely caused by clinical alterations related to GM1 gangliosidosis, as this is consistent with the established onset of clinical symptoms in this mouse model (21).